GB201701787D0 - Non-effervescent ganulates containing n-acetylcysteine - Google Patents

Non-effervescent ganulates containing n-acetylcysteine

Info

Publication number
GB201701787D0
GB201701787D0 GBGB1701787.2A GB201701787A GB201701787D0 GB 201701787 D0 GB201701787 D0 GB 201701787D0 GB 201701787 A GB201701787 A GB 201701787A GB 201701787 D0 GB201701787 D0 GB 201701787D0
Authority
GB
United Kingdom
Prior art keywords
ganulates
acetylcysteine
effervescent
ganulates containing
effervescent ganulates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1701787.2A
Other versions
GB2552728A (en
GB2552728A9 (en
GB2552728B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alpex Pharma SA
Original Assignee
Alpex Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpex Pharma SA filed Critical Alpex Pharma SA
Publication of GB201701787D0 publication Critical patent/GB201701787D0/en
Publication of GB2552728A publication Critical patent/GB2552728A/en
Publication of GB2552728A9 publication Critical patent/GB2552728A9/en
Application granted granted Critical
Publication of GB2552728B publication Critical patent/GB2552728B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
GB1701787.2A 2016-02-23 2017-02-03 Non-effervescent granulates containing N-acetylcysteine Active GB2552728B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1651458A FR3047898B1 (en) 2016-02-23 2016-02-23 NON-EFFERVESCENT GRANULES CONTAINING N-ACETYLCYSTEINE.

Publications (4)

Publication Number Publication Date
GB201701787D0 true GB201701787D0 (en) 2017-03-22
GB2552728A GB2552728A (en) 2018-02-07
GB2552728A9 GB2552728A9 (en) 2019-07-17
GB2552728B GB2552728B (en) 2019-11-20

Family

ID=56117855

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1701787.2A Active GB2552728B (en) 2016-02-23 2017-02-03 Non-effervescent granulates containing N-acetylcysteine

Country Status (4)

Country Link
CH (1) CH712181B1 (en)
DE (1) DE102017103033A1 (en)
FR (1) FR3047898B1 (en)
GB (1) GB2552728B (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19931708A1 (en) * 1999-07-08 2001-01-18 Bayer Ag Process for the preparation of rapidly disintegrating solid pharmaceutical preparations
EP1449525A1 (en) * 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
TR200900882A2 (en) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Pharmaceutical compositions with high bioavailability, masked by taste and odor.
IT1399492B1 (en) 2010-04-13 2013-04-19 Alpex Pharma Sa EFFERVESCENT PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCISTEIN.
EP2571499A1 (en) * 2010-05-18 2013-03-27 Mahmut Bilgic Pharmaceutical composition comprising n- acetylcysteine and a xanthine
US8747894B2 (en) * 2012-05-08 2014-06-10 Alpex Pharma S.A. Effervescent compositions containing N-acetylcysteine

Also Published As

Publication number Publication date
FR3047898A1 (en) 2017-08-25
GB2552728A (en) 2018-02-07
CH712181B1 (en) 2020-09-30
GB2552728A9 (en) 2019-07-17
FR3047898B1 (en) 2020-09-18
DE102017103033A1 (en) 2017-08-24
CH712181A2 (en) 2017-08-31
GB2552728B (en) 2019-11-20

Similar Documents

Publication Publication Date Title
GB2558478B (en) Copy-Redirect on write
GB2552625B (en) Cartridge
ZA201801354B (en) Evaporation source
IL254550B (en) Toilet-paper-roll holder
IL265139B (en) Dopamine-b-hydroxylase inhibitors
IL262674A (en) Crystals
GB201612860D0 (en) Inhibitors
AU363495S (en) Crate
HK1248194B (en) Lid
HK1216969A2 (en) Suitcase
GB201507720D0 (en) Access provision
AU201617244S (en) Case
GB201516363D0 (en) Enclosed Space
GB201504272D0 (en) Unprinting cartridge
GB201516700D0 (en) Metail Mother
GB201510383D0 (en) Rectangular-faced enclosures
EP3387530C0 (en) Secure computing
GB201701787D0 (en) Non-effervescent ganulates containing n-acetylcysteine
GB201509839D0 (en) One piece
GB201504820D0 (en) Retention time standard
GB201621467D0 (en) Modified bulgeomers
GB2544782B (en) Solution
GB201616374D0 (en) Modified bulgeomers
TWM533428U (en) Flip-flop
GB201614858D0 (en) Modified Bulgeomers